Eremurus persicus
Eremurus persicus · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Eremurus persicus is a distinctive botanical species known for its unique phytochemical profile. Scientific investigations have identified several key compounds within the plant, including 4-amino-4-carboxychroman-2-one, Aloesaponol III 8-methyl ether, Auraptene, and Corchoionoside A. Research focuses primarily on the leaf and root components to understand their medicinal potential. Specifically, the root extract has demonstrated significant relevance in studies concerning Leishmania infections. This makes the plant a subject of great interest for pharmacological development and disease management.
- Synonyms
- Asphodelus Persicus · Henningia Aucheriana · 3 more
- Common names
- Not available
- Family
- Asphodelaceae
- Distribution
- Africa
- Plant Parts
- Leaf · Root
Classification
Synonyms
Eremurus persicus is a plant species that has been documented under several different botanical names throughout history. Scientific literature identifies various synonyms for this species, including Asphodelus persicus and Eremurus aucherianus. The taxonomic complexity of the plant is further evidenced by its classification as Henningia aucheriana. Additional historical records also link it to the names Henningia persica and Henningia sikesara. Understanding these various nomenclatural relationships is essential for accurate botanical identification and research.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Eremurus persicus is a distinctive botanical specimen belonging to the kingdom Plantae. Within this vast biological realm, the plant is classified under the class Equisetopsida. It further refines its identity through its placement in the order Asparagales. As a member of the Asphodelaceae family, it shares characteristics with many related flowering species. Ultimately, this plant is defined by its specific classification within the genus Eremurus.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asparagales |
| Family | Asphodelaceae |
| Genus | Eremurus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Eremurus persicus is a resilient plant with a broad geographical footprint spanning across diverse Asian landscapes. Within the temperate regions of Western Asia, this species can be found thriving in both Afghanistan and Iran. Its reach extends further into the tropical climates of the Indian Subcontinent, specifically throughout Pakistan. Additionally, the plant maintains a notable presence within the West Himalaya region. This wide distribution highlights the remarkable adaptability of the species to varying environmental conditions across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Eremurus persicus is characterized by its distinct herb growth form. This plant is naturally self-supporting, allowing it to stand upright in its environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Eremurus persicus is an endemic medicinal plant from Iran that has recently undergone significant phytochemical investigation. Research has successfully identified several key secondary metabolites within the plant, including corchoionoside A and 4-amino-4-carboxychroman-2-one. Furthermore, the species contains important compounds such as auraptene and imperatorin, which were reported for the first time in the Eremurus genus. The plant's root extract is also a source of Aloesaponol III 8-methyl ether, a novel compound that shows promise in treating leishmaniosis. These findings highlight the complex chemical profile of E. persicus and its potential value in pharmaceutical development.
Conditions
Eremurus persicus demonstrates significant medicinal potential through its ability to treat leishmaniosis. Research into the plant's root extract has shown that it is an effective tool for treating Leishmania infections. Specifically, the isolated compound (R)-ASME from the plant treats Leishmania infantum promastigotes viability by inhibiting it and inducing morphological alterations. This inhibition occurs alongside mitochondrial potential deregulation within the parasites. Consequently, the plant serves as a promising source for developing new drugs to combat these parasitic diseases.
Preparations
Eremurus persicus is prepared as a root extract to facilitate the phytochemical characterization of its medicinal properties. This specific extraction process allowed researchers to isolate the novel compound (R)-(-)-Aloesaponol III 8-Methyl Ether. By using the root extract, scientists were able to elucidate the chemical structure and optical configuration of this potent molecule. The biological investigation of the extract revealed that it contains components capable of inhibiting Leishmania infantum promastigotes. Ultimately, preparing the plant as a root extract proved essential in identifying a promising new candidate for leishmaniosis treatment.
Parts used
Eremurus persicus is an endemic medicinal plant widely distributed throughout Iran that possesses significant pharmacological potential. The leaves of this species have a long history of traditional use as both a food source and a medicinal resource. Scientific investigations into its leaf fractions have successfully isolated several unique secondary metabolites, including corchoionoside A and isoorientin. Furthermore, research focusing on the root extract has led to the discovery of novel compounds like (R)-(-)-aloesaponol III 8-methyl ether. This specific root-derived molecule has demonstrated promising activity in inhibiting Leishmania infantum, offering a potential new avenue for treating leishmaniosis.